Literature DB >> 26919571

Moving towards a new class of vaccines for non-infectious chronic diseases.

Bryce Chackerian1, Kathryn M Frietze1.   

Abstract

Keywords:  Immunotherapy; VLPs; cost-effectiveness; self-antigens; virus-like particles

Mesh：

Substances：

Year:  2016        PMID： 26919571     DOI： 10.1586/14760584.2016.1159136

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  10 in total

Review 1.  Biomaterial strategies for generating therapeutic immune responses.

Authors:  Sean H Kelly; Lucas S Shores; Nicole L Votaw; Joel H Collier
Journal:  Adv Drug Deliv Rev       Date:  2017-04-25       Impact factor: 15.470

2.  A single-dose, implant-based, trivalent virus-like particle vaccine against "cholesterol checkpoint" proteins.

Authors:  Oscar A Ortega-Rivera; Jonathan K Pokorski; Nicole F Steinmetz
Journal:  Adv Ther (Weinh)       Date:  2021-03-11

3.  Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis.

Authors:  Louise Goksøyr; Anders B Funch; Anna K Okholm; Thor G Theander; Willem Adriaan de Jongh; Charlotte M Bonefeld; Adam F Sander
Journal:  Vaccines (Basel)       Date:  2022-05-23

4.  Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.

Authors:  Somayeh Pouyanfard; Gloria Spagnoli; Lorenzo Bulli; Kathrin Balz; Fan Yang; Caroline Odenwald; Hanna Seitz; Filipe C Mariz; Angelo Bolchi; Simone Ottonello; Martin Müller
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

5.  Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis.

Authors:  Isabell S von Loga; Aadil El-Turabi; Luke Jostins; Jadwiga Miotla-Zarebska; Jennifer Mackay-Alderson; Andris Zeltins; Ida Parisi; Martin F Bachmann; Tonia L Vincent
Journal:  Ann Rheum Dis       Date:  2019-03-12       Impact factor: 19.103

6.  Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses.

Authors:  Antonia Fettelschoss-Gabriel; Victoria Fettelschoss; Florian Olomski; Katharina Birkmann; Franziska Thoms; Maya Bühler; Martin Kummer; Andris Zeltins; Thomas M Kündig; Martin F Bachmann
Journal:  Allergy       Date:  2018-11-25       Impact factor: 13.146

7.  An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein.

Authors:  Lucie Jelínková; Hugo Jhun; Allison Eaton; Nikolai Petrovsky; Fidel Zavala; Bryce Chackerian
Journal:  NPJ Vaccines       Date:  2021-01-21       Impact factor: 7.344

8.  Novel expression of coat proteins from thermophilic bacteriophage ΦIN93 and evaluation for assembly into virus-like particles.

Authors:  Lukai Zhai; Dana Anderson; Elizabeth Bruckner; Ebenezer Tumban
Journal:  Protein Expr Purif       Date:  2021-06-29       Impact factor: 1.650

9.  Virus-like particle display of HER2 induces potent anti-cancer responses.

Authors:  Arianna Palladini; Susan Thrane; Christoph M Janitzek; Jessica Pihl; Stine B Clemmensen; Willem Adriaan de Jongh; Thomas M Clausen; Giordano Nicoletti; Lorena Landuzzi; Manuel L Penichet; Tania Balboni; Marianna L Ianzano; Veronica Giusti; Thor G Theander; Morten A Nielsen; Ali Salanti; Pier-Luigi Lollini; Patrizia Nanni; Adam F Sander
Journal:  Oncoimmunology       Date:  2018-01-05       Impact factor: 8.110

Review 10.  New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue.

Authors:  Karl D Brune; Mark Howarth
Journal:  Front Immunol       Date:  2018-06-26       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.